Punicalagin and ellagic acid induce apoptosis in prostate cancer cells through some basic pathways, such as the introduction of cytochrome c in the cell cytoplasm, upregulation of Bax, and downregulation of B cell lymphoma/leukemia-2 (Bcl-2) (64). The gene discussed is CYCS; the disease is prostate carcinoma.